Evolving biomanufacturing technology
The NevoLine™ Upstream platform is an innovative biomanufacturing technology that delivers cost-effective viral production. This new generation platform builds on the successful NevoLine™ sIPV proof-of-concept designed to deliver affordable inactivated polio vaccine.
The high-performance, intensified platform features a flexible design to accommodate viral vaccine, gene therapy, and oncolytic virus production. With the NevoLine™ Upstream platform, automated GMP clinical and commercial-scale upstream production is achieved within a 3 m² footprint.
Watch & Listen
Redefining upstream virus production
The NevoLine™ Upstream platform accommodates all unit operations from inoculation to clarification and concentration within a compact module.
Pre-defined single-use assemblies can be selected and combined to meet your process requirements.
Integrating the scale-X nitro bioreactor for commercial production
The scale-X nitro bioreactor enables commercial-scale production in a compact size while offering 200 m² or 600 m² surface for cell growth.
The structured fixed-bed design enables a linear scale-up from the scale-X carbo. As part of the NevoLine Upstream, the bioreactor benefits from the automation and integration offered by the platform.
Click & Learn
An integrated solution designed for flexibility
Achieving rapid commercial-scale capacity with drastically reduced operational expenditures and footprint.
Integrating all unit steps in a compact design with automated operations for reproducible results.
Combining pre-defined single-use assemblies for a multitude of process designs.
Building production capacity easily in new or existing facility for rapid market access.
Services & maintenance
Shortcut to your success
Our experienced Bioprocess & Field Services team is available to support you to quickly and efficiently start your development activities. From the installation of the equipment to process training and maintenance, they are committed to provide the support you need.